Cabaletta Bio, Inc. (CABA) Balance Sheet

The balance sheet trajectory is defined by the steady consumption of equity to fund pre-revenue operations, as evidenced by the growing negative retained earnings balance. While the company has periodically bolstered its cash position through financing activities, the underlying trend is one of capital depletion, which may indicate a finite runway absent additional funding or a path to revenue.

The liquidity profile appears robust on a static basis, with a high current ratio and a cash-heavy asset mix. However, the sustainability of this position is contingent on the pace of cash consumption; the recent surge in cash suggests a financing event, which temporarily extends the runway but does not alter the fundamental burn trajectory.

The minimal debt load suggests management has avoided adding fixed financial obligations during this capital-intensive, pre-revenue phase. This conservative leverage profile preserves financial flexibility but also implies that future capital needs will likely continue to be met through equity issuance, which carries its own dilutive risks.

The quality of the equity base is entirely dependent on external financing, as the massive accumulated deficit reflects years of R&D spending without revenue. This structure means the book value of equity is a poor proxy for intrinsic value and is highly sensitive to market sentiment and the company's ability to raise additional capital.